301234.Sz

The company maintains a strong liquidity position, with a current ratio of 6.27, indicating that it has sufficient current assets to cover its current liabilities multiple times over. However, the company's liquidity risk is assessed as medium, primarily due to a negative net cash position after subtracting total debt. The company's capital structure is largely equity-driven, with total equity of 761,018,360 CNY and minimal long-term debt of 680,420 CNY, suggesting a conservative leverage approach.

In terms of profitability, the company's return on equity (ROE) is 2.48%, and its return on assets (ROA) is 2.17%, both of which are below the typical thresholds for high-performing firms in the medical equipment and supplies industry. The company's operating margin is 5.06% (calculated as operating income of 23,150,710 CNY divided by revenue of 458,282,120 CNY), which is relatively modest compared to industry benchmarks. The net profit margin is 4.12% (calculated as net income of 18,893,020 CNY divided by revenue of 458,282,120 CNY), further indicating that the company is not generating significant net returns relative to its revenue.

The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess the geographic or product concentration of its business. However, the lack of detailed segment reporting may suggest a relatively concentrated business model, which could expose the company to higher operational and market risks.

The company's growth trajectory is not explicitly outlined in the available data, but its operating cash flow of 73,384,910 CNY and free cash flow of 17,607,230 CNY suggest that it is generating positive cash from operations. The company's capital expenditures of -19,776,290 CNY indicate that it is not investing heavily in new assets, which may limit its long-term growth potential. The absence of detailed outlook data for the current and next fiscal years makes it challenging to assess the company's future growth prospects.

The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the available data. However, the company's liquidity risk remains a concern due to its negative net cash position. The company's credit risk is not explicitly assessed, but its low leverage and strong equity position suggest that it is in a relatively stable financial position.

There are no recent events or filings mentioned in the available data that would significantly impact the company's operations or financial performance. The absence of recent transcripts or filings may indicate a lack of material developments in the company's business or regulatory environment.